EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for RCAR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical EPS Diluted (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
September 30, 2022 -0.0046
June 30, 2022 -0.026
March 31, 2022 -0.0198
December 31, 2021 -0.0154
September 30, 2021 -0.0194
June 30, 2021 -0.0104
March 31, 2021 -0.0059
December 31, 2020 -0.0291
September 30, 2020 -0.0323
June 30, 2020 -0.0345
March 31, 2020 -0.0134
December 31, 2019 -0.0134
September 30, 2019 -0.0128
June 30, 2019 -0.0063
March 31, 2019 -0.006
December 31, 2018 -0.0069
September 30, 2018 -0.0058
June 30, 2018 -0.01
March 31, 2018 -0.01
December 31, 2017 -0.01
September 30, 2017 -0.01
June 30, 2017 -0.02
March 31, 2017 -0.01
December 31, 2016 -0.01
September 30, 2016 -0.0043
Date Value
June 30, 2016 -0.01
March 31, 2016 -0.01
December 31, 2015 -0.01
September 30, 2015 -0.0044
June 30, 2015 -0.0032
March 31, 2015 -0.004
December 31, 2014 -0.0038
September 30, 2014 -0.02
June 30, 2014 -0.01
March 31, 2014 -0.004
December 31, 2013 -0.0045
September 30, 2013 -0.0029
June 30, 2013 -0.0013
March 31, 2013 -0.0003
December 31, 2012 -0.0007
September 30, 2012 -0.0006
June 30, 2012 -0.0012
March 31, 2012 0.00
December 31, 2011 0.01
September 30, 2011 0.02
June 30, 2011 0.04
March 31, 2011 0.00
December 31, 2010 -0.08
September 30, 2010 0.02
June 30, 2010 0.03

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Athersys, Inc. --
Marizyme, Inc. --
Mera Pharmaceuticals, Inc. --
Nanologix, Inc. --
PhaseRx, Inc. --